Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04591691 · ClinicalTrials.gov registry record
C-myc Biomarker Study for Diabetic Foot Ulcers
A clinical trial, sponsored by University of Michigan.
- Completed
- Registry status
- 140
- Enrollment target
NCT04591691 is a clinical trial that has completed, run by University of Michigan. The registered enrollment target is 140 participants.
The verdict
NCT04591691 has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- 140 participants
- Enrollment target
Study Summary
This is a multi-center observational cohort study of patients with diabetic foot ulcers (DFU) to develop and validate potential tissue-based biomarkers that predict complete wound healing. Eligible and consented participants will begin standard of care treatment after collection of tissue specimens from the wound's edge. An additional tissue specimen is collected at 4 weeks if clinically indicated. Tissues will be tested for c-myc and phosphorylated glucocorticoid receptor (p-GR) levels using validated protocols at a central laboratory. Participants will be followed weekly for up to 12 weeks or until complete wound healing (whichever occurs first). One final assessment 2 weeks after complete wound healing will occur to confirm healing.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 140 participants |
| Start Date | 2020-10-14 |
| Est. Completion | 2023-07-20 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04591691
The ClinicalTrials.gov registry entry for NCT04591691 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 140 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT04591691 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04591691 about?
NCT04591691 is a clinical study titled "C-myc Biomarker Study for Diabetic Foot Ulcers". This is a multi-center observational cohort study of patients with diabetic foot ulcers (DFU) to develop and validate potential tissue-based biomarkers that predict complete wound healing. Eligible and consented participants will begin standard of care treatment after collection of tissue specimens ...
What is the current status of trial NCT04591691?
This trial is currently completed. The enrollment target is 140 participants. The study started on 2020-10-14. Estimated completion is 2023-07-20.
Who is sponsoring clinical trial NCT04591691?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.